FLC Price sensitive 12 May 2026, 8:58 AM

FLC Wins Strategic $3.7M Industrial Water Contract in US

Fluence Corporation Ltd

Fluence Wins $3.7M Industrial Water Contract in US

Key points

  • Secured significant industrial water treatment contract in Texas
  • Contract valued at approximately $3.7 million
  • Facility to produce up to 1.5 million gallons per day of water supply

Full summary

Fluence Corporation Limited (ASX: FLC) has secured a significant industrial water treatment contract in Texas, valued at approximately USD $3.7 million. The contract is for the design and construction of a water treatment plant utilizing ultrafiltration (UF) and reverse osmosis (RO) technologies for a prominent U.S. manufacturer located in Texas. Upon completion, the facility will be capable of producing up to 1.5 million gallons per day of water supply and enable the customer to treat groundwater sourced from an on-site well for use as cooling tower makeup. Amid increasing water scarcity challenges in Texas, the system will significantly reduce the customer's dependence on municipal water supplies while enhancing long-term operational resilience. The plant is expected to be installed and fully operational by the end of 2026. Fluence's high-efficiency, quick-to-deploy systems are designed to maximize water recovery and sustainability by achieving greater than 90% recovery of feedwater. This project demonstrates how advanced water treatment technology can help industrial manufacturers maintain production while supporting the community's broader water conservation goals during periods of extreme drought. The contract reflects a growing shift among industrial operators toward sustainable water management strategies, and Fluence is well-positioned to help customers rapidly deploy decentralized treatment systems that improve resilience, reduce environmental impact, and protect critical industrial operations.

Summary generated by a large language model. Please interpret with care.

Sign in for more about this company, including guidance changes and other insights.
Sign in